By Pharma Intelligence : Lyxumia (lixisenatide) for the treatment of type 2 diabetes is once-daily GLP-1 from Sanofi 's ( SAN ) stable. It is a potential head to head competitor to Novo Nordisk's ( NVO ) Victoza ($2.1b - 2013 annual sales
exceed its target of having five compounds in human studies by the end of 2015 ("5 x 15"), and a recent deal with Sanofi ( SNY ) gives Alnylam development funding, a motivated commercial partner, and the perception that it has been vetted by
Sanofi 's ( SNY ) subisidiary plans to resubmit its sBLA for Lemtrada this quarter. It believes that it has addressed all the issues the FDA raised in its December 27 CRL . It will not pursue its previously-announced appeal of the FDA's decision. ( GCVRZ ) 1 comment!
producing these products include, Eli Lilly ( LLY ), Merck ( MRK ), P&G, Novartis ( NVS ), AstraZeneca ( AZN ), Sanofi - Aventis ( SNY ), Allergan ( AGN ) and Bausch & Lomb. Here's a quick rundown. Sustained Release Success Across Many Disease
compound annual growth rate, and we think undervalued Sanofi SNY is well-positioned to benefit from the demographic ..... well above its weighted average cost of capital. Sanofi SNY On the pipeline, Sanofi is making strides, which increases our confidence
Despite disappointing early trials data, Sanofi ( SNY ) rolls the dice and starts production of its dengue fever vaccine . The firm has invested more than 300 million euros in a manufacturing
Sanofi ( SNY ) has joined the auction for Merck's ( MRK ) over-the-counter health-products ..... says Barclays. Merck's unit would be a "good fit" geographically for Sanofi , as 70% of its revenue comes from the U.S. Other interested parties
PARIS, March 19 (Reuters) - French drugmaker Sanofi said its Sanofi Pasteur unit had signed a long-term cooperation deal with South Korea's SK Chemical Co to develop and market a vaccine against pneumococcal infection.
current leader considering the long-term success of Ventolin, but Roche ( OTCQX:RHHBY ), AstraZeneca ( AZN ), Sanofi ( SNY ) and Teva (TEVA) all plan to compete in the space. Novel antibody-based drugs target key inflammatory chemicals
Sanofi 's strong ..... should mean Sanofi will have ..... insulin market, Sanofi 's Lantus ..... lifestyles. Sanofi 's increasingly ..... exemplary. Since Chris Viehbacher took over ..... understanding of Sanofi 's home country ..... May 2010, Serge Weinberg took over